HCR.20.086 – EESAT2

Route: Health care research, sickness prevention and treatment

Cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?

In EESAT2, we will use advanced biochemical as well as novel ICT technologies to produce new and novel-to-nature antimicrobial peptides with little/no resistance development. Advanced synthetic biological and chemical techniques will be used to further optimize lead antimicrobials.


AMR antimicrobials


Organisation Leiden University (LEI)
Name Prof. dr. N.I. (Nathaniel) Martin
E-mail n.i.martin@biology.leidenuniv.nl